{"id":45067,"date":"2021-12-28T06:00:02","date_gmt":"2021-12-28T11:00:02","guid":{"rendered":"https:\/\/clarkstonconsulting.com\/?p=45067"},"modified":"2022-04-17T22:01:05","modified_gmt":"2022-04-18T02:01:05","slug":"3pl-and-serialization","status":"publish","type":"post","link":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/","title":{"rendered":"3PL and Serialization Vendor Selection for a Biopharmaceutical Company"},"content":{"rendered":"

Clarkston Consulting recently partnered with a client\u00a0<\/span>for\u00a0<\/span>a v<\/span>endor selection project<\/span> for 3PL and s<\/span>erialization<\/span><\/span>\u00a0<\/span><\/span>capabilities.\u00a0<\/span>This client\u00a0<\/span>is a\u00a0<\/span>virtual\u00a0<\/span>biopharmaceutical company that focuses on\u00a0developing and commercializing innovative treatments for\u00a0inflammatory skin diseases and\u00a0other\u00a0medical dermatologica<\/span>l<\/span> conditions. <\/span><\/span><\/span>The client is readying for their commercial launch <\/span>was looking for partners\u00a0<\/span>with\u00a0<\/span>leading practices and services to assist with their growth journey.<\/span>\u00a0To achieve\u00a0<\/span>this<\/span>, the client engaged Clarkston to support their vendor selections for\u00a0<\/span>a 3PL\u00a0<\/span>with w<\/span>arehousing and o<\/span>rder-to-c<\/span>ash services and\u00a0<\/span>a s<\/span>erialization<\/span><\/span> s<\/span><\/span>olution<\/span>\u00a0provider<\/span><\/span>.\u00a0<\/span><\/span><\/p>\n

Download the Full Case Study Here<\/a> <\/span><\/p>\n

The primary objectives of the selection processes were to select vendors with sophisticated capabilities that would support our clients current strategic and operational needs while creating a foundation for scalable growth.<\/span><\/span> In this effort,<\/span>\u00a0Clarkston leveraged our\u00a0<\/span>partner selection toolkit developed over many years of building relationships with providers, assessing\u00a0<\/span>their<\/span><\/span>\u00a0<\/span><\/span>capabilities<\/span> and managing <\/span>selections<\/span><\/span>\u00a0<\/span><\/span>on\u00a0<\/span>behalf of our clients.<\/span><\/span>\u00a0<\/span><\/span><\/p>\n

The toolkit<\/span><\/span>\u00a0<\/span><\/span>accelerates<\/span>\u00a0the selection time<\/span>line through<\/span><\/span>\u00a0<\/span><\/span>tools and tem<\/span>plates t<\/span>hat<\/span><\/span>\u00a0<\/span><\/span>serve<\/span>\u00a0a<\/span>s a\u00a0<\/span>f<\/span>oundation for each client’s unique selection of analysis and deliverables. Through the combination of quantitative and qualitative methodology with additional sessions and demos to select the finalist, Clarkston was able to help the client determine the best fit aligned to present and future needs.<\/span><\/span><\/p>\n

Contributions by Robin Dolan<\/em><\/p>\n

Download our 3PL and Serialization Vendor Selection for a Biopharmaceutical Company\u00a0case study<\/a>, learn more about our Life Sciences Consulting services<\/a> or contact us below.<\/em><\/h2>\n

Contact Us to Learn More<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Clarkston Consulting recently partnered with a client\u00a0for\u00a0a vendor selection project for 3PL and serialization\u00a0capabilities.\u00a0This client\u00a0is a\u00a0virtual\u00a0biopharmaceutical company that focuses on\u00a0developing and commercializing innovative treatments for\u00a0inflammatory skin diseases and\u00a0other\u00a0medical dermatological conditions. The client is readying for their commercial launch was looking for partners\u00a0with\u00a0leading practices and services to assist with their growth journey.\u00a0To achieve\u00a0this, the client engaged […]<\/p>\n","protected":false},"author":68,"featured_media":45030,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[31,18,23,22,706],"tags":[568,522,534,711],"class_list":["post-45067","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotech","category-pharma","category-quality-compliance","category-supply-chain","category-life-sciences","tag-case-study","tag-serialization","tag-vendor-selection-advisory","tag-precommercial","insight_type-case-study"],"acf":[],"yoast_head":"\n3PL and Serialization Vendor Selection for a Biopharmaceutical Company<\/title>\n<meta name=\"description\" content=\"Clarkston recently partnered with a biopharmaceutical company\u00a0for\u00a0a vendor selection project\u00a0for 3PL and\u00a0Serialization\u00a0capabilities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3PL and Serialization Vendor Selection for a Biopharmaceutical Company\" \/>\n<meta property=\"og:description\" content=\"Clarkston recently partnered with a biopharmaceutical company\u00a0for\u00a0a vendor selection project\u00a0for 3PL and\u00a0Serialization\u00a0capabilities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/\" \/>\n<meta property=\"og:site_name\" content=\"Clarkston Consulting\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ClarkstonConsulting\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-28T11:00:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-18T02:01:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/clarkstonconsulting.com\/wp-content\/uploads\/2021\/12\/3PL-and-Serialization-Vendor-Selection-for-a-Biopharmaceutical-Organization_FEATURED.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Mike Hackett\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Clarkston_Inc\" \/>\n<meta name=\"twitter:site\" content=\"@Clarkston_Inc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mike Hackett\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/\",\"url\":\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/\",\"name\":\"3PL and Serialization Vendor Selection for a Biopharmaceutical Company\",\"isPartOf\":{\"@id\":\"https:\/\/clarkstonconsulting.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/clarkstonconsulting.com\/wp-content\/uploads\/2021\/12\/3PL-and-Serialization-Vendor-Selection-for-a-Biopharmaceutical-Organization_FEATURED.jpg\",\"datePublished\":\"2021-12-28T11:00:02+00:00\",\"dateModified\":\"2022-04-18T02:01:05+00:00\",\"author\":{\"@id\":\"https:\/\/clarkstonconsulting.com\/#\/schema\/person\/c212afec5d47f85d070f5a790a8cd274\"},\"description\":\"Clarkston recently partnered with a biopharmaceutical company\u00a0for\u00a0a vendor selection project\u00a0for 3PL and\u00a0Serialization\u00a0capabilities.\",\"breadcrumb\":{\"@id\":\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#primaryimage\",\"url\":\"https:\/\/clarkstonconsulting.com\/wp-content\/uploads\/2021\/12\/3PL-and-Serialization-Vendor-Selection-for-a-Biopharmaceutical-Organization_FEATURED.jpg\",\"contentUrl\":\"https:\/\/clarkstonconsulting.com\/wp-content\/uploads\/2021\/12\/3PL-and-Serialization-Vendor-Selection-for-a-Biopharmaceutical-Organization_FEATURED.jpg\",\"width\":600,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/clarkstonconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"3PL and Serialization Vendor Selection for a Biopharmaceutical Company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/clarkstonconsulting.com\/#website\",\"url\":\"https:\/\/clarkstonconsulting.com\/\",\"name\":\"Clarkston Consulting\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/clarkstonconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/clarkstonconsulting.com\/#\/schema\/person\/c212afec5d47f85d070f5a790a8cd274\",\"name\":\"Mike Hackett\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/clarkstonconsulting.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/70f3799223493bb4b208f9d0317379dfc5be007c9582cfe21edf508974399969?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/70f3799223493bb4b208f9d0317379dfc5be007c9582cfe21edf508974399969?s=96&d=mm&r=g\",\"caption\":\"Mike Hackett\"},\"url\":\"https:\/\/clarkstonconsulting.com\/insights\/author\/mhackett\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"3PL and Serialization Vendor Selection for a Biopharmaceutical Company","description":"Clarkston recently partnered with a biopharmaceutical company\u00a0for\u00a0a vendor selection project\u00a0for 3PL and\u00a0Serialization\u00a0capabilities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/","og_locale":"en_US","og_type":"article","og_title":"3PL and Serialization Vendor Selection for a Biopharmaceutical Company","og_description":"Clarkston recently partnered with a biopharmaceutical company\u00a0for\u00a0a vendor selection project\u00a0for 3PL and\u00a0Serialization\u00a0capabilities.","og_url":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/","og_site_name":"Clarkston Consulting","article_publisher":"https:\/\/www.facebook.com\/ClarkstonConsulting\/","article_published_time":"2021-12-28T11:00:02+00:00","article_modified_time":"2022-04-18T02:01:05+00:00","og_image":[{"width":600,"height":450,"url":"https:\/\/clarkstonconsulting.com\/wp-content\/uploads\/2021\/12\/3PL-and-Serialization-Vendor-Selection-for-a-Biopharmaceutical-Organization_FEATURED.jpg","type":"image\/jpeg"}],"author":"Mike Hackett","twitter_card":"summary_large_image","twitter_creator":"@Clarkston_Inc","twitter_site":"@Clarkston_Inc","twitter_misc":{"Written by":"Mike Hackett","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/","url":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/","name":"3PL and Serialization Vendor Selection for a Biopharmaceutical Company","isPartOf":{"@id":"https:\/\/clarkstonconsulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#primaryimage"},"image":{"@id":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#primaryimage"},"thumbnailUrl":"https:\/\/clarkstonconsulting.com\/wp-content\/uploads\/2021\/12\/3PL-and-Serialization-Vendor-Selection-for-a-Biopharmaceutical-Organization_FEATURED.jpg","datePublished":"2021-12-28T11:00:02+00:00","dateModified":"2022-04-18T02:01:05+00:00","author":{"@id":"https:\/\/clarkstonconsulting.com\/#\/schema\/person\/c212afec5d47f85d070f5a790a8cd274"},"description":"Clarkston recently partnered with a biopharmaceutical company\u00a0for\u00a0a vendor selection project\u00a0for 3PL and\u00a0Serialization\u00a0capabilities.","breadcrumb":{"@id":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#primaryimage","url":"https:\/\/clarkstonconsulting.com\/wp-content\/uploads\/2021\/12\/3PL-and-Serialization-Vendor-Selection-for-a-Biopharmaceutical-Organization_FEATURED.jpg","contentUrl":"https:\/\/clarkstonconsulting.com\/wp-content\/uploads\/2021\/12\/3PL-and-Serialization-Vendor-Selection-for-a-Biopharmaceutical-Organization_FEATURED.jpg","width":600,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/clarkstonconsulting.com\/insights\/3pl-and-serialization\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clarkstonconsulting.com\/"},{"@type":"ListItem","position":2,"name":"3PL and Serialization Vendor Selection for a Biopharmaceutical Company"}]},{"@type":"WebSite","@id":"https:\/\/clarkstonconsulting.com\/#website","url":"https:\/\/clarkstonconsulting.com\/","name":"Clarkston Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clarkstonconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/clarkstonconsulting.com\/#\/schema\/person\/c212afec5d47f85d070f5a790a8cd274","name":"Mike Hackett","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/clarkstonconsulting.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/70f3799223493bb4b208f9d0317379dfc5be007c9582cfe21edf508974399969?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/70f3799223493bb4b208f9d0317379dfc5be007c9582cfe21edf508974399969?s=96&d=mm&r=g","caption":"Mike Hackett"},"url":"https:\/\/clarkstonconsulting.com\/insights\/author\/mhackett\/"}]}},"_links":{"self":[{"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/posts\/45067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/users\/68"}],"replies":[{"embeddable":true,"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/comments?post=45067"}],"version-history":[{"count":4,"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/posts\/45067\/revisions"}],"predecessor-version":[{"id":46930,"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/posts\/45067\/revisions\/46930"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/media\/45030"}],"wp:attachment":[{"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/media?parent=45067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/categories?post=45067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarkstonconsulting.com\/wp-json\/wp\/v2\/tags?post=45067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}